Illumina | ILMN - Loan Capital


Illumina reported $1.49B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agilent USD 3.05B 0 Dec/2025
Bio Techne USD 260M 40M Dec/2025
Bio-Rad Laboratories USD 1.2B 300K Dec/2025
Boston Scientific USD 11.01B 19M Dec/2025
Bruker USD 1.85B 131.7M Dec/2025
Charles River Laboratories USD 2.14B 49.09M Dec/2025
Danaher USD 17.56B 855M Mar/2026
Dentsply International USD 2.02B 2M Dec/2025
Edwards Lifesciences USD 600M 1.7M Mar/2026
Illumina USD 1.49B 496M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Laboratory Of America USD 5.15B 800K Dec/2025
Mettler Toledo International USD 2.09B 58.01M Dec/2025
Myriad Genetics USD 119.9M 400K Dec/2025
OraSure Technologies USD 100K 17K Dec/2025
Pacific Biosciences Of California USD 645.38M 223K Dec/2025
Quest Diagnostics USD 5.16B 12M Mar/2026
Quidel USD 2.47B 2.47B Dec/2025
Repligen USD 542.21M 4.29M Dec/2025
Revvity USD 2.63B 543K Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Standard Biotools USD 299K 0 Dec/2025
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
Waters USD 1.41B 460.24M Dec/2025